SCHEMBL1505391

SCHEMBL1505391

COc1ccc(C)cc1-c1nnn(C(C)(C)C)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.42
▸ KMT2A Q03164 2/20 0.40
▸ ACHE P22303 1/20 0.40
▸ NR1I2 O75469 7/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ USP2 O75604 2/20 0.36
▸ GAA P10253 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8788397 0.81 NPSR1 (0.55) GRM5KMT2AALDH1A1CYP3A4NPSR1
SCHEMBL9078674 0.72 AOC3 (0.48) KMT2AALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL9430611 0.71 ABCG2 (0.45) ALDH1A1KDM4ELMNANPSR1SMN1; SMN2
SCHEMBL24022853 0.70 ACHE (0.48) GRM5KMT2AACHEALDH1A1CYP3A4
SCHEMBL9180022 0.70 TSHR (0.36) GRM5KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL14951063 0.68 ACHE (0.50) GRM5KMT2AACHEALDH1A1CYP3A4
SCHEMBL21889509 0.68 LTA4H (0.55) ALDH1A1KDM4ELMNASMN1; SMN2USP2
SCHEMBL9257076 0.68 ALDH1A1 (0.39) KMT2AALDH1A1KDM4ELMNANPSR1
SCHEMBL9429885 0.65 ABCG2 (0.40) NPSR1SMN1; SMN2NPC1RAB9AL3MBTL1
SCHEMBL7015622 0.65 PBRM1 (0.41) ALDH1A1KDM4ELMNANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3112352-A1 OPIOID RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2017-01-04 — — EP claimed
EP-1725537-B1 NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-07-13 — — EP claimed
EP-3112352-B1 OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-11-21 — — EP disclosed
EP-3112352-A1 OPIOID RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2017-01-04 — — EP disclosed
EP-2653465-B1 Opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2016-07-13 — — EP disclosed
EP-2573068-B9 Process for preparing intermediates of compounds useful as opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2015-08-26 — — EP disclosed
EP-2573068-B1 Process for preparing intermediates of compounds useful as opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2014-12-31 — — EP disclosed
EP-2653465-A1 Opioid receptor modulators Janssen Pharmaceutica NV (BE) 2013-10-23 — — EP disclosed
EP-2298744-B1 Opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2013-06-26 — — EP disclosed
EP-2573068-A1 Process for preparing intermediates of compounds useful as opioid receptor modulators Janssen Pharmaceutica NV (BE) 2013-03-27 — — EP disclosed
EP-1725537-B1 NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-07-13 — — EP disclosed
EP-2298744-A2 Opioid receptor modulators Janssen Pharmaceutica NV (BE) 2011-03-23 — — EP disclosed
Send feedback